Andrea Janikova Selected Research

Nucleophosmin

3/2018

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Janikova Research Topics

Disease

11	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2018 - 10/2008
8	Lymphoma (Lymphomas) 01/2021 - 10/2008
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2014
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2022 - 01/2018
3	Neoplasms (Cancer) 01/2020 - 04/2015
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 03/2018
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 01/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2015 - 08/2011
1	COVID-19 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Fatigue 01/2019
1	Nausea 01/2019
1	Anemia 01/2019
1	Vomiting 01/2019
1	Residual Neoplasm 12/2018
1	Genomic Instability 03/2018
1	Disease Progression 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2015
1	Necrosis 04/2015
1	Bone Marrow Diseases (Bone Marrow Disease) 11/2009
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2009

Drug/Important Bio-Agent (IBA)

13	Rituximab (Mabthera)FDA Link 08/2022 - 04/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2016
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2018 - 12/2016
1	polatuzumab vedotinIBA 08/2022
1	Bendamustine Hydrochloride FDA Link 08/2022
1	TNF Receptor-Associated Factor 4IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	ruxolitinibIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	plerixafor FDA Link 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Cyclin D1IBA 01/2019
1	resminostatIBA 01/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2018
1	Anaplastic Lymphoma KinaseIBA 03/2018
1	NucleophosminIBA 03/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	coltuximab ravtansineIBA 01/2018
1	Procarbazine (Matulane)FDA Link 12/2016
1	Vincristine (Oncovin)FDA LinkGeneric 12/2016
1	polyhistidineIBA 04/2015
1	LigandsIBA 04/2015
1	human TNFSF10 proteinIBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	fludarabineIBA 11/2009
1	SteroidsIBA 06/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2009
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2008

Therapy/Procedure

8	Therapeutics 07/2020 - 11/2009
3	Radiotherapy 12/2016 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Cardiac Rehabilitation 01/2022
1	Transplantation 01/2020
1	Stem Cell Transplantation 01/2019
1	Immunotherapy 01/2018
1	Intravenous Administration 06/2014